For decades, biomedical and
pharmaceutical researchers have worked to devise new and more effective
therapeutics to treat diseases affecting the central nervous system. The blood-brain barrier effectively protects the brain, but poses a profound challenge to
drug delivery across this barrier. Many traditional drugs cannot cross the blood-brain barrier in appreciable concentrations, with less than 1% of most drugs reaching the central nervous system, leading to a lack of available treatments for many
central nervous system diseases, such as
stroke,
neurodegenerative disorders, and
brain tumors. Due to the ineffective nature of most treatments for
central nervous system disorders, the development of novel drug delivery systems is an area of great interest and active research. Multiple novel strategies show promise for effective central nervous system
drug delivery, giving potential for more effective and safer
therapies in the future. This review outlines several novel
drug delivery techniques, including intranasal
drug delivery, nanoparticles,
drug modifications, convection-enhanced infusion, and ultrasound-mediated
drug delivery. It also assesses possible clinical applications, limitations, and examples of current clinical and preclinical research for each of these
drug delivery approaches. Improved central nervous system
drug delivery is extremely important and will allow for improved treatment of
central nervous system diseases, causing improved
therapies for those who are affected by
central nervous system diseases.